Quarterly report pursuant to Section 13 or 15(d)

NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Oct. 31, 2011
Oct. 31, 2010
Oct. 31, 2011
Oct. 31, 2010
Revenues        
Product sales $ 19,844 $ 15,869 $ 39,606 $ 42,829
Total revenue 19,844 15,869 39,606 42,829
Cost of revenues 6,036 2,854 21,711 9,781
Gross profit 13,808 13,015 17,895 33,048
Expenses        
Sales and marketing 3,600 0 128,730 7,000
Compensation expense 322,765 0 628,327 0
Legal & professional fees 8,161 0 68,115 25,151
General and administrative 83,013 32,193 249,052 99,410
Total operating expenses 417,539 32,193 1,074,224 131,561
Net loss from operations (403,731) (19,178) (1,056,329) (98,513)
Other income (expense)        
Interest expense (33,421) (26,642) (66,841) (81,566)
Total other expense (33,421) (26,642) (66,841) (81,566)
Net loss $ (437,152) $ (45,820) $ (1,123,170) $ (180,079)
Basic loss per share $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted average shares outstanding 374,087,581 348,387,581 370,932,961 348,387,581